Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy
Author:
Funder
Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11010-021-04149-7.pdf
Reference75 articles.
1. Konig IR, Fuchs O (2017) What is precision medicine? Eur Respir J. https://doi.org/10.1183/13993003.00391-2017
2. Yu KH, Snyder M (2016) omics profiling in precision oncology. Mol Cell Proteom 15:2525–2536. https://doi.org/10.1074/mcp.O116.059253
3. Schutte M, Ogilvie LA, Rieke DT, Lange BMH, Yaspo ML, Lehrach H (2017) Cancer precision medicine: why more is more and DNA is not enough. Public Health Genom 20:70–80. https://doi.org/10.1159/000477157
4. Schoenfeld AJ, Chan JM, Kubota D, Sato H, Rizvi H, Daneshbod Y, Chang JC, Paik PK, Offin M, Arcila ME, Davare MA, Shinde U, Pe’er D, Rekhtman N, Kris MG, Somwar R, Riely GJ, Ladanyi M, Yu HA (2020) Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer. Clin Cancer Res 26:2654–2663. https://doi.org/10.1158/1078-0432.ccr-19-3563
5. Belli S, Esposito D, Servetto A, Pesapane A, Formisano L, Bianco R (2020) c-Src and EGFR inhibition in molecular cancer therapy: what else can we improve? Cancers 12:1489
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel drug susceptibility testing AIEgen with spatiotemporal resolved progress-reporting characteristic for therapy of drug-resistant tumor;Materials Today;2022-12
2. Predicting prognosis and clinical features of the tumor microenvironment based on ferroptosis score in patients with breast cancer;Scientific Reports;2022-06-23
3. SIRT1 siRNA-loaded lipid nanoparticles enhanced doxorubicin-induced cell death in prostate cancer cell lines;Journal of Drug Delivery Science and Technology;2021-12
4. Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy;Molecular and Cellular Biochemistry;2021-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3